| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/20/2005 | CN1607948A Composition comprising paracetamol and a bitterness masking component |
| 04/20/2005 | CN1607947A Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol |
| 04/20/2005 | CN1607940A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/20/2005 | CN1607938A Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606997A Plaster for bone disease |
| 04/20/2005 | CN1606994A Nanometer compound Chinese medicinal formulation for treating brain atrophy and its preparing method |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197592C Pure traditional Chinese medicinal preparation for treating child's epilepsy disease and its preparing method |
| 04/20/2005 | CN1197581C Use of P-benzaldehyde-O-beta-D-allopyranoside for treating depression |
| 04/20/2005 | CN1197569C New treatments for neuropathy |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881829 Complexing drug with substance p |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881738 Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | US6881733 Serotonergic benzofurans |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881725 Administering to a subject a purine derivative to reduce traumatic pain, neuropathic pain, organ pain and pain associated with diseases |
| 04/19/2005 | US6881409 Compositions and methods for promoting nerve regeneration |
| 04/19/2005 | US6881208 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/19/2005 | CA2273894C Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 04/19/2005 | CA2172162C Optically active imidazolidinone derivative and process for producing the same |
| 04/19/2005 | CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 04/14/2005 | WO2005033310A1 Pim-1 specific dsrna compounds |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2005033115A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033059A1 Compounds for the treatment of diseases associated with the formation of amyloid fibrils |
| 04/14/2005 | WO2005032592A1 Hypnotic composition |
| 04/14/2005 | WO2005032587A1 Vaccine for prevention and treatment of opiate addiction |
| 04/14/2005 | WO2005032556A1 Method for reducing pain |
| 04/14/2005 | WO2005032552A1 Hypnotic composition |
| 04/14/2005 | WO2005032546A1 Hypnotic composition |
| 04/14/2005 | WO2005032543A1 Hypnotic composition |
| 04/14/2005 | WO2005032538A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | WO2005032537A1 Method for preventing and/or treating neurodegenerative diseases |
| 04/14/2005 | WO2005032536A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | WO2005032535A1 Nerve regeneration promoters |
| 04/14/2005 | WO2005032520A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | WO2005032519A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | WO2005032518A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | WO2005032517A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | WO2005032234A2 Agent for reducing ill effects of acute alcohol intoxication |
| 04/14/2005 | WO2005021005A3 Process for the preparation of 1,4-benzodiazepine derivatives |
| 04/14/2005 | WO2005016327A3 Treatment of sleep disorders with cholinesterase inhibitors |
| 04/14/2005 | WO2005004860A3 Novel solid pharmaceutical composition comprising amisulpride |
| 04/14/2005 | WO2004112786A3 Gaboxadol for treating depression and other affective disorders |
| 04/14/2005 | WO2004096216A3 Use of a topical medicament comprising riluzole |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050080275 Process for the preparation of simvastatin |
| 04/14/2005 | US20050080269 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide |
| 04/14/2005 | US20050080266 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 04/14/2005 | US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080130 Compounds foriImaging alzheimer's disease |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080099 Methods and kits for treating depression or preventing deterioration of cognitive function |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080085 Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof |
| 04/14/2005 | US20050080081 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/14/2005 | US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders) |
| 04/14/2005 | US20050080074 Such as (+-)-1,3,4,10b-tetrahydro-7-trifluoromethoxy-pyrazino[2,1-a]isoindol-6(2H)-one for treatment of metabolic disorders, central nervous system disorders, and gastrointestinal disorders |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080016 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 04/14/2005 | US20050080012 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050079612 Use of obg3 for promoting central nervous system remyelination |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079217 Tablet with protective coatings; Parkinson's disease; sexual disorders |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079174 Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | CA2743269A1 Methods and kits for enhancing ability to learn in a puppy or kitten |
| 04/14/2005 | CA2582018A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | CA2582008A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | CA2582007A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | CA2554954A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2541533A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | CA2540895A1 Combinations of ziconotide and opioids for reducing pain |
| 04/14/2005 | CA2540681A1 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |